Cargando…

Association Between Medication Adherence and Risk of COPD in Adult Asthma Patients: A Retrospective Cohort Study in Canada

BACKGROUND: Poor adherence to prescribed asthma medications and risk of severe asthma exacerbations have been well established. However, the effects of changes in asthma medication compliance levels and subsequent risk of COPD is unknown and yet to be investigated. This study investigated the indepe...

Descripción completa

Detalles Bibliográficos
Autores principales: Asamoah-Boaheng, Michael, Farrell, Jamie, Bonsu, Kwadwo Osei, Oyet, Alwell, Midodzi, William K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621002/
https://www.ncbi.nlm.nih.gov/pubmed/36325197
http://dx.doi.org/10.2147/CLEP.S370623
_version_ 1784821443037495296
author Asamoah-Boaheng, Michael
Farrell, Jamie
Bonsu, Kwadwo Osei
Oyet, Alwell
Midodzi, William K
author_facet Asamoah-Boaheng, Michael
Farrell, Jamie
Bonsu, Kwadwo Osei
Oyet, Alwell
Midodzi, William K
author_sort Asamoah-Boaheng, Michael
collection PubMed
description BACKGROUND: Poor adherence to prescribed asthma medications and risk of severe asthma exacerbations have been well established. However, the effects of changes in asthma medication compliance levels and subsequent risk of COPD is unknown and yet to be investigated. This study investigated the independent effect of medication adherence (MA) and asthma severity levels on the risk of COPD. METHODS: We used four linked administrative health databases from the Population data BC to identify asthma patients aged 18 years and older between January 1, 1998 and December 31, 1999 without diagnosis of COPD. The primary event was time-to-COPD diagnosis during the follow-up period (January 1, 2000 to December 31, 2018). The proportion of days covered (PDC) – was used as a surrogate measure for medication adherence (MA) assessed at optimal-level (≥ 0.80), Intermediate-level (0.50–0.79), and low-level (< 0.5) of adherence. A propensity adjusted analysis with Marginal Structural Cox (MSC) model was employed to estimate the adjusted hazard ratios (aHR) and 95% confidence intervals (95% CI) for the effect of medication adherence and asthma severity over time. RESULTS: At cohort entry, the sample included 68,211 asthma patients with an overall mean age of 48.2 years. The 18-year incidence of COPD in asthma patients was 9.8 per 1000-persons year. In an inverse weighted propensity adjusted analysis of the MSC model, higher MA levels were significantly associated with decreased risk of COPD as follows: optimal-level (aHR: 0.19, 95% CI: 0.17–0.24); Intermediate-level (aHR: 0.20, 95% CI: 0.18, 0.23) compared to the low-level adherence group. A significant increase in COPD risk was observed in severe asthma patients with low medication adherence (aHR: 1.72, 95% CI: 1.52–1.93), independent of other patient factors. CONCLUSION: Optimal (≥ 0.80) and intermediate adherence (0.5 to 0.79) levels were associated with reduced risk of COPD incidence over time. Interventions aimed at improving adherence to prescribed medications in adult asthma patients should be intensified to reduce their risk of COPD.
format Online
Article
Text
id pubmed-9621002
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-96210022022-11-01 Association Between Medication Adherence and Risk of COPD in Adult Asthma Patients: A Retrospective Cohort Study in Canada Asamoah-Boaheng, Michael Farrell, Jamie Bonsu, Kwadwo Osei Oyet, Alwell Midodzi, William K Clin Epidemiol Original Research BACKGROUND: Poor adherence to prescribed asthma medications and risk of severe asthma exacerbations have been well established. However, the effects of changes in asthma medication compliance levels and subsequent risk of COPD is unknown and yet to be investigated. This study investigated the independent effect of medication adherence (MA) and asthma severity levels on the risk of COPD. METHODS: We used four linked administrative health databases from the Population data BC to identify asthma patients aged 18 years and older between January 1, 1998 and December 31, 1999 without diagnosis of COPD. The primary event was time-to-COPD diagnosis during the follow-up period (January 1, 2000 to December 31, 2018). The proportion of days covered (PDC) – was used as a surrogate measure for medication adherence (MA) assessed at optimal-level (≥ 0.80), Intermediate-level (0.50–0.79), and low-level (< 0.5) of adherence. A propensity adjusted analysis with Marginal Structural Cox (MSC) model was employed to estimate the adjusted hazard ratios (aHR) and 95% confidence intervals (95% CI) for the effect of medication adherence and asthma severity over time. RESULTS: At cohort entry, the sample included 68,211 asthma patients with an overall mean age of 48.2 years. The 18-year incidence of COPD in asthma patients was 9.8 per 1000-persons year. In an inverse weighted propensity adjusted analysis of the MSC model, higher MA levels were significantly associated with decreased risk of COPD as follows: optimal-level (aHR: 0.19, 95% CI: 0.17–0.24); Intermediate-level (aHR: 0.20, 95% CI: 0.18, 0.23) compared to the low-level adherence group. A significant increase in COPD risk was observed in severe asthma patients with low medication adherence (aHR: 1.72, 95% CI: 1.52–1.93), independent of other patient factors. CONCLUSION: Optimal (≥ 0.80) and intermediate adherence (0.5 to 0.79) levels were associated with reduced risk of COPD incidence over time. Interventions aimed at improving adherence to prescribed medications in adult asthma patients should be intensified to reduce their risk of COPD. Dove 2022-10-27 /pmc/articles/PMC9621002/ /pubmed/36325197 http://dx.doi.org/10.2147/CLEP.S370623 Text en © 2022 Asamoah-Boaheng et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Asamoah-Boaheng, Michael
Farrell, Jamie
Bonsu, Kwadwo Osei
Oyet, Alwell
Midodzi, William K
Association Between Medication Adherence and Risk of COPD in Adult Asthma Patients: A Retrospective Cohort Study in Canada
title Association Between Medication Adherence and Risk of COPD in Adult Asthma Patients: A Retrospective Cohort Study in Canada
title_full Association Between Medication Adherence and Risk of COPD in Adult Asthma Patients: A Retrospective Cohort Study in Canada
title_fullStr Association Between Medication Adherence and Risk of COPD in Adult Asthma Patients: A Retrospective Cohort Study in Canada
title_full_unstemmed Association Between Medication Adherence and Risk of COPD in Adult Asthma Patients: A Retrospective Cohort Study in Canada
title_short Association Between Medication Adherence and Risk of COPD in Adult Asthma Patients: A Retrospective Cohort Study in Canada
title_sort association between medication adherence and risk of copd in adult asthma patients: a retrospective cohort study in canada
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621002/
https://www.ncbi.nlm.nih.gov/pubmed/36325197
http://dx.doi.org/10.2147/CLEP.S370623
work_keys_str_mv AT asamoahboahengmichael associationbetweenmedicationadherenceandriskofcopdinadultasthmapatientsaretrospectivecohortstudyincanada
AT farrelljamie associationbetweenmedicationadherenceandriskofcopdinadultasthmapatientsaretrospectivecohortstudyincanada
AT bonsukwadwoosei associationbetweenmedicationadherenceandriskofcopdinadultasthmapatientsaretrospectivecohortstudyincanada
AT oyetalwell associationbetweenmedicationadherenceandriskofcopdinadultasthmapatientsaretrospectivecohortstudyincanada
AT midodziwilliamk associationbetweenmedicationadherenceandriskofcopdinadultasthmapatientsaretrospectivecohortstudyincanada